DeutschNewstral
Article
Mmarketwatch.com on 2018-03-14 22:17
Solid Biosciences shares plunge as FDA puts study on clinical hold
Related news
- MSolid Biosciences shares crater 63% on clinical hold for lead productmarketwatch.com
- MSolid Biosciences shares slide 5% premarket after update of FDA clinical hold on its main product candidatemarketwatch.com
- MUPDATE: Solid Biosciences stock surges on news FDA has removed clinical hold on SGT-001 DMD treatmentmarketwatch.com
FDA puts clinical hold on Inovio's late-stage immunotherapy studybizjournals.com- FDA intervenes for 3rd time in Solid Biosciences' Duchenne drug testsbizjournals.com
- Shares of Solid Biosciences crater as FDA halts Duchenne gene therapy trialbizjournals.com
Shares in Vancouver biotech firm plunge after FDA finds ‘no clinical benefit’ to COVID-19 drugoregonlive.com- IShould you buy or sell ALLO stock after shares plunge 37% as FDA halts clinical trial?invezz.com
- BSolid Biosciences Stock Crashes Over Safety Concerns About Its Gene Therapybarrons.com
- MNot even Solid Biosciences’ latest disclosure could sour its market debutmarketwatch.com
- MConcert Pharma stock drops 10% after FDA puts hair loss drug on clinical holdmarketwatch.com
- MRegeneron stock slumps nearly 2% after FDA puts hold on midstage clinical trialmarketwatch.com
- MInovio Pharma stock down 14% after FDA puts clinical hold on proposed late-stage trialmarketwatch.com
U.S. FDA puts on hold Covaxin’s phase 2/3 clinical trialsThe Hindu- FDA approves Harmony BioSciences' sleep disorder drugbizjournals.com
- MSolid Biosciences stock are up on DMD study newsmarketwatch.com
- MImmunoGen, Solid Biosciences and Insys lead Wednesday’s biotech losersmarketwatch.com
Valent BioSciences new orchard product gains FDA approvaldailyherald.com- FDA lifts suspension of Juno clinical trialbizjournals.com
- FDA clears ALung device for clinical trialsbizjournals.com